Fibrocell Science, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2017. For the quarter, the company reported operating loss was $4,596,000 against $5,017,000 a year ago. Loss before income taxes was $115,000 against $2,299,000 a year ago. Net loss was $115,000 against $2,299,000 a year ago. Net loss attributable to common stockholders was $308,000 against $2,299,000 a year ago. Basic and diluted loss per share was $0.02 against $0.16 a year ago. For the nine months, the company reported operating loss was $14,077,000 against $22,004,000 a year ago. Loss before income taxes was $19,140,000 against $11,798,000 a year ago. Net loss was $19,140,000 against $11,798,000 a year ago. Net loss attributable to common stockholders was $23,303,000 against $11,798,000 a year ago. Basic and diluted loss per share was $1.58 against $0.0.94 per share diluted a year ago. The company used approximately $12.9 million in cash for operations during the nine months ended September 30, 2017, as compared to approximately $25.6 million used for the same nine-month period in 2016.